drugset / Trial / NCT01285388
Safety, Tolerability and Pharmacokinetic Study of MB12066 in Healthy Volunteers
RandomizedParallel-groupQuadruple-blindScreening
Summary
The purpose of this study is to investigate the safety and tolerability of MB12066 after a single oral dose and to investigate the pharmacokinetic characteristics of MB12066 after a single oral dose.
Timeline
- Start
- 2010-07
- Primary completion
- 2011-01
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LAPACHONE | Small molecule | 10 mg | Oral |
| Subject | LAPACHONE | Small molecule | 30 mg | Oral |
| Subject | LAPACHONE | Small molecule | 100 mg | Oral |
| Subject | LAPACHONE | Small molecule | 150 mg | Oral |
| Subject | LAPACHONE | Small molecule | 200 mg | Oral |